|
Palo Alto, CA, - November 15, 2004 – Telik, Inc. (Nasdaq: TELK) announced that company management will present an update at the CSFB Healthcare Conference in Phoenix, AZ on Wednesday, November 17, 2004 at 5:00 p.m. Mountain/7:00 p.m. Eastern. A live webcast of the presentation will be accessible at Telik’s website, www.telik.com. An archive of the webcast will be available on the Telik website through November 24, 2004 .
About Telik, Inc.
Telik, Inc. of Palo Alto , CA is a biopharmaceutical company working to discover, develop and commercialize small molecule drugs to treat serious diseases. The company’s most advanced drug development candidate is TELCYTA™ (TLK286), a tumor-activated small molecule product candidate that is in Phase 3 registration trials in advanced ovarian and non-small cell lung cancer. Telik’s product candidates were discovered using its proprietary drug discovery technology, TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Additional information is available at www.telik.com.
###
Contact:
Carol DeGuzman
Senior Director, Corporate Communications
Telik, Inc.
Tel 650-845-7728
Email cdeguzman@telik.com
Go to: 2004
Press Releases2003
Press ReleasesEvents
|
